Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
IMTX similar filings
- 14 May 24 Current report (foreign)
- 21 Mar 24 Current report (foreign)
- 22 Jan 24 Immatics Announces Proposed Public Offering
- 14 Nov 23 Current report (foreign)
- 8 Nov 23 Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial
- 24 Oct 23 Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy
- 11 Sep 23 Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
Filing view
External links